Showing results (181-190 of 364) with videos related to
Sort By:
Pageof 37
Teratology|October 1, 1988
Embryonic catch-up growth after exposure to the ketone body D,L,-beta-hydroxybutyrate in vitroL Shum, T W SadlerDiabetologia|May 1, 1991
Recovery by mouse embryos following teratogenic exposure to ketosisL Shum, T W SadlerClinical Pharmacology and Therapeutics|July 1, 1975
Digoxin pharmacokinetics: role of renal failure in dosage regimen designJ R Koup, W J Jusko, C M Elwood, et al.JAMA|November 3, 1978
Gentamicin tissue accumulation and nephrotoxic reactionsJ J Schentag, T J Cumbo, W J Jusko, et al.The Journal of Pharmacology and Experimental Therapeutics|May 21, 1999
A pharmacokinetic/pharmacodynamic model for recombinant human growth hormone effects on induction of insulin-like growth factor I in monkeysY N Sun, H J Lee, R R Almon, et al.Clinical Chemistry|June 1, 1979
Liquid-chromatographic assay of diazepam and its major metabolites in plasmaJ J MacKichan, W J Jusko, P K Duffner, et al.Pharmaceutical Research|October 1, 1993
Enhancement of tissue delivery and receptor occupancy of methylprednisolone in rats by a liposomal formulationE V Mishina, R M Straubinger, N A Pyszczynski, et al.Biochemical Pharmacology|June 15, 1985
Protein binding of oxazepam and its glucuronide conjugates to human albuminF D Boudinot, C A Homon, W J Jusko, et al.American Journal of Physiology. Endocrinology and Metabolism|May 26, 2016
Mathematical modeling of the circadian dynamics of the neuroendocrine-immune network in experimentally induced arthritisR Rao, D DuBois, R Almon, et al.Journal of Pharmacokinetics and Biopharmaceutics|March 31, 1999
Fourth-generation model for corticosteroid pharmacodynamics: a model for methylprednisolone effects on receptor/gene-mediated glucocorticoid receptor down-regulation and tyrosine aminotransferase induction in rat liverY N Sun, D C DuBois, R R Almon, et al.Pageof 37